RESUMO
Infant formulas are designed to provide sufficient energy and the necessary nutrients to support the growth and development of newborns. Currently, research on the functions of formula milk powder focuses on clinical research and cell experiments, and there were many cell experiments that investigated the effect of infant formulas on cellular growth. However, most of the cells used are tumor cell lines, which are unable to simulate the real digestion process of an infant. In this study, we innovatively proposed a method that integrates human small intestinal organoids (SIOs) with transcriptomics and metabolomics analysis. We induced directed differentiation of human embryonic stem cells into SIOs and simulated the intestinal environment of newborns with them. Then, three kinds of 1-stage infant formulas from the same brand were introduced to simulate the digestion, absorption, and metabolism of the infant intestine. The nutritional value of each formula milk powder was examined by multi-omics sequencing methods, including transcriptomics and metabolomics analysis. Results showed that there were significant alterations in gene expression and metabolites in the three groups of SIOs after absorbing different infant formulas. By analyzing transcriptome and metabolome data, combined with GO, KEGG, and GSEA analysis, we demonstrated the ability of SIOs to model the different aspects of the developing process of the intestine and discovered the correlation between formula components and their effects, including Lactobacillus lactis and lactoferrin. The study reveals the effect and mechanisms of formula milk powder on the growth and development of infant intestines and the formation of immune function. Furthermore, our method can help to construct a multi-level assessment model, detect the effects of nutrients, and evaluate the interactions between nutrients, which is helpful for future research and development of infant powders.
RESUMO
Despite the remarkable clinical efficacy of cancer immunotherapy, considerable patients fail to benefit from it due to primary or acquired resistance. Tumours frequently hijack diverse epigenetic mechanisms to evade immune detection, thereby highlighting the potential for pharmacologically targeting epigenetic regulators to restore the impaired immunosurveillance and re-sensitise tumours to immunotherapy. Herein, we demonstrated that KDM4-targeting chemotherapeutic drug JIB-04, epigenetically triggered the tumour-intrinsic innate immune responses and immunogenic cell death (ICD), resulting in impressive antitumour effects. Specifically, JIB-04 induced H3K9 hypermethylation through specific inhibition of the KDM4 family (KDM4A-D), leading to impaired DNA repair signalling and subsequent DNA damage. As a result, JIB-04 not only activated the tumour-intrinsic cyclic GMP-AMP synthase (cGAS)-STING pathway via DNA-damage-induced cytosolic DNA accumulation, but also promoted ICD, releasing numerous damage-associated molecular patterns. Furthermore, JIB-04 induced adaptive resistance through the upregulation of programmed death-ligand 1 (PD-L1), which could be overcome with additional PD-L1 blockade. In human tumours, KDM4B expression was negatively correlated with clinical outcomes, type I interferon signatures, and responses to immunotherapy. In conclusion, our results demonstrate that targeting KDM4 family can activate tumour-intrinsic innate sensing and immunogenicity, and synergise with immunotherapy to improve antitumour outcomes.
Assuntos
Aminopiridinas , Antígeno B7-H1 , Hidrazonas , Neoplasias , Humanos , Neoplasias/tratamento farmacológico , Neoplasias/genética , Imunidade Inata/genética , DNA/metabolismo , Histona Desmetilases com o Domínio Jumonji/genéticaRESUMO
The emergence of segmented mirrors is expected to solve the design, processing, manufacturing, testing, and launching of space telescopes of large apertures. However, with the increase in the number of sub-mirrors, the sensing and correction of co-phase errors in segmented mirrors will be very difficult. In this paper, an independent three-dimensional method for sub-mirror co-phase error sensing and correction method is proposed. The method is based on a wide spectral modulation transfer function (MTF), mask, population optimization algorithm, and online model-free correction. In this method, the sensing and correction process of each sub-mirror co-phase error is independent of each other, so the increase in the number of sub-mirrors will not increase the difficulty of the method. This method can sense and correct the co-phase errors of three dimensions of the sub-mirror, including piston, tip, and tilt, even without modeling the optical system, and has a wide detection range and high precision. And the efficiency is high because the sub-mirrors can be corrected simultaneously in parallel. Simulation results show that the proposed method can effectively sense and correct the co-phase errors of the sub-mirrors in the range [-50λ, 50λ] in three dimensions with high precision. The average RMSE value in 100 experiments of the true co-phase error values and the experimental co-phase error values of one of the six sub-mirrors is 2.358 × 10-7λ.